𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adverse Events of Subcutaneous Recombinant Human Erythropoietin Therapy: Results of a Controlled Multicenter European Study

✍ Scribed by Horst Klinkmann; Lothar Wieczorek; Paul Scigalla


Book ID
115310467
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
568 KB
Volume
17
Category
Article
ISSN
0160-564X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Recombinant human anti–transforming grow
✍ Christopher P. Denton; Peter A. Merkel; Daniel E. Furst; Dinesh Khanna; Paul Eme πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 1 views

## Abstract ## Objective To evaluate CAT‐192, a recombinant human antibody that neutralizes transforming growth factor Ξ²1 (TGFΞ²1), in the treatment of early‐stage diffuse cutaneous systemic sclerosis (dcSSc). ## Methods Patients with SSc duration of <18 months were randomly assigned to the place